Dr Philip H Walker, MD | |
2414 Kohler Memorial Dr, Sheboygan, WI 53081-3129 | |
(920) 457-4461 | |
(920) 459-1483 |
Full Name | Dr Philip H Walker |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 2414 Kohler Memorial Dr, Sheboygan, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326017435 | NPI | - | NPPES |
32101500 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 21099 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Philip H Walker, MD 2414 Kohler Memorial Dr, Sheboygan, WI 53081-3129 Ph: (920) 457-4461 | Dr Philip H Walker, MD 2414 Kohler Memorial Dr, Sheboygan, WI 53081-3129 Ph: (920) 457-4461 |
News Archive
Unilife Corporation today announced that it has signed an exclusive five-year agreement with Stason Pharmaceuticals Inc, a U.S.-based pharmaceutical company, to market the Unitractâ„¢ 1mL safety syringe in Japan, China and Taiwan. Stason's Taiwan-based strategic alliance affiliate, Standard Chem. and Pharm. Co., LTD, will act as the primary distributor of the product within these designated territories.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.
Tarix Orphan LLC, a privately held biopharmaceutical company focused on the treatment of rare neuromuscular disorders and connective tissue diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation to TXA127 (angiotensin 1-7) to reduce skeletal muscle damage and fibrosis and thereby improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 2 days ago
Mr. Muhammad Rasheed Khan Orakzai, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3400 Union Ave, Sheboygan, WI 53081 Phone: 920-802-2100 | |
Adeel Pervez, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Tochukwu Hilary Igwe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3400 Union Ave, Sheboygan, WI 53081 Phone: 920-802-2100 Fax: 920-802-1500 | |
Nicholas Gustafson, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1222 N 23rd St, Sheboygan, WI 53081 Phone: 920-457-6800 | |
Tyler Qiu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 |